Lightstone Ventures — 2018 Investments
1 investments dated 2018 · listed companies and verified rows first · show all
Nuvaira develops the dNerva Lung Denervation System, a catheter-based device used in a one-time, outpatient bronchoscopic procedure that disrupts pulmonary nerve input to treat chronic obstructive pulmonary disease (COPD).
HardwareHealthtechMedical DevicesMinneapolis, US
Martin Mayse(Founder)inSteve Dimmer(Founder)inDennis Wahr(President & CEO)inLisa Flaherty(Chief Strategy Officer)inSteve Sathre(Vice President of Finance)inSteve Paidosh(Vice President of Operations)
Board seatMichael A, CarusiHenry PlainMichael A. CarusiMike CarusiHank Plain· per SEC Form D
Co-investorsWindham Capital PartnersEndeavour VisionMorgenthalerQiming Venture PartnersRichard King Mellon FoundationSplit Rock Partners+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.








